This trial is designed to improve how paramedics treat seizures in children by making the midazolam dose age-based.
1 Primary · 2 Secondary · Reporting Duration: Between arrival to the emergency department and 10 minutes after arrival
Active Control
Experimental Treatment
6000 Total Participants · 2 Treatment Groups
Primary Treatment: Standardized seizure protocol · No Placebo Group · Phase 3
Age 6 - 13 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: